Spatially Variable Genes DOI

Shantagoud Biradar,

Chaaya Suresh,

Nagashri Nanjundeshwara

et al.

Advances in medical diagnosis, treatment, and care (AMDTC) book series, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 28

Published: Dec. 17, 2024

The clinical translation of spatial transcriptomics represents cancer diagnosis and therapy based on the role heterogeneity cancer-associated fibroblasts (CAFs) within tumor microenvironment (TME). Recent developments in have enabled a detailed characterization organization cellular interactions tumors. data integration, multi-omics approaches, along with developing standardized protocols is essential for effective translation. experimental selection regimes factorial designs reveals novel insights into biomarkers prognostic value CAFs. incorporation optogenetics advancements bio-engineered gene circuits, therapeutics tissue engineering further underscores potential to refine patient stratification improve treatment responsiveness. By integrating workflows, this work aims advance personalized therapies biology.

Language: Английский

Stimuli-responsive smart nanomaterials for theranostics of urological cancers DOI

Yi Xu,

Madineh Moradialvand, Francesca Della Sala

et al.

Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 539, P. 216745 - 216745

Published: May 1, 2025

Language: Английский

Citations

0

Prebiotic Peptide Synthesis: How Did Longest Peptide Appear? DOI

Yuling Yang,

Zhibiao Wang, Jin Bai

et al.

Journal of Molecular Evolution, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 24, 2025

Language: Английский

Citations

0

Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics DOI Creative Commons
Stephanie R. Jackson, Joseph P. Flemming,

Kübra Karagoz

et al.

Journal of Extracellular Biology, Journal Year: 2024, Volume and Issue: 3(11)

Published: Oct. 30, 2024

The translation of pre-clinical anti-cancer therapies to regulatory approval has been promising, but slower than hoped. While innovative and effective treatments continue achieve or seek approval, setbacks are often attributed a lack efficacy, failure clinical endpoints, dose-limiting toxicities. Successful efforts have characterized by the development therapeutics designed specifically deliver optimal dosing tumour cells while minimizing off-target toxicity. Much effort devoted rational design application synthetic nanoparticles serve as targeted therapeutic delivery vehicles. Several challenges successful this modality vehicles include induction protracted immune response that results in their rapid systemic clearance, manufacturing cost, stability, biocompatibility. Extracellular vesicles (EVs) heterogeneous class endogenous biologically produced lipid bilayer mediate intercellular communication carrying bioactive macromolecules capable modifying cellular phenotypes local distant cells. By genetic, chemical, metabolic methods, extracellular can be engineered display targeting moieties on surface transporting specific cargo modulate pathological processes following uptake target cell populations. This review will survey types EVs, composition cargoes, strategies employed increase targeting, uptake, release, potential

Language: Английский

Citations

2

Hybrid nano-stimulator for specific amplification of oxidative stress and precise tumor treatment DOI
Ting Yang, Zihan Liu, Tong Zhang

et al.

Journal of drug targeting, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 14

Published: June 4, 2024

The use of reactive oxygen species (ROS) to target cancer cells has become a hot topic in tumor therapy.

Language: Английский

Citations

0

Spatially Variable Genes DOI

Shantagoud Biradar,

Chaaya Suresh,

Nagashri Nanjundeshwara

et al.

Advances in medical diagnosis, treatment, and care (AMDTC) book series, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 28

Published: Dec. 17, 2024

The clinical translation of spatial transcriptomics represents cancer diagnosis and therapy based on the role heterogeneity cancer-associated fibroblasts (CAFs) within tumor microenvironment (TME). Recent developments in have enabled a detailed characterization organization cellular interactions tumors. data integration, multi-omics approaches, along with developing standardized protocols is essential for effective translation. experimental selection regimes factorial designs reveals novel insights into biomarkers prognostic value CAFs. incorporation optogenetics advancements bio-engineered gene circuits, therapeutics tissue engineering further underscores potential to refine patient stratification improve treatment responsiveness. By integrating workflows, this work aims advance personalized therapies biology.

Language: Английский

Citations

0